• 대한치과교정학회지
• /
• 제52권1호
• /
• pp.75-79
• /
• 2022

Objective: To investigate remineralizing effect of three fluoride regimens on artificially demineralized enamel around orthodontic bracket by analyzing mineral density (MD) acquired from micro-computed tomography (micro-CT). Methods: Forty-eight bracket bonded bovine incisors were prepared to create demineralized enamel (DE) surface. The samples were divided into four groups according to the fluoride regimen: 1) no fluoridation, 2) 1.23% acidulated phosphate fluoride (APF) gel, 3) fluoridated toothpaste, and 4) 0.05% sodium fluoride mouthwash. Micro-CT was scanned after demineralization (T0), and 2 weeks (T1) and 4 weeks (T2) of fluoridation. Results: APF gel showed highest remineralization of DE during T1-T0 interval among the groups (p < 0.05); followed by toothpaste, mouthwash and no fluoridation. APF gel and toothpaste demonstrated significant increase in MD after 4 weeks of application (p < 0.05). Conclusions: Remineralization effects of three fluoride regimens were depicted through micro-CT analysis, of which APF gel was most effective.

• The Journal of Advanced Prosthodontics
• /
• 제8권3호
• /
• pp.172-180
• /
• 2016

PURPOSE. The purpose of this study was to analyze the antimicrobial, antioxidant activity and cytotoxicity of Dendropanax morbifera $L{\acute{e}}veille$ extract for assessing whether Dendropanax morbifera $L{\acute{e}}veille$ can be used for the development of natural mouthwash and denture cleaning solution. MATERIALS AND METHODS. The extract was obtained from branches of Dendropanax morbifera $L{\acute{e}}veille$. The solvent fractions were acquired by fractionating Dendropanax morbifera $L{\acute{e}}veille$ extract using n-hexane, ethyl acetate, chloroform and butanol solvent. Paper disc test was used to evaluate the antimicrobial and antifungal activity of Dendropanax morbifera $L{\acute{e}}veille$ extract and solvent fractions against Streptococcus mutans and Candida albicans. The analysis of antioxidant activity was carried out through DPPH radical scavenging assay. The cytotoxicity of Dendropanax morbifera $L{\acute{e}}veille$ extract was analyzed through MTT assay using normal human oral keratinocytes. RESULTS. Dendropanax morbifera $L{\acute{e}}veille$ extract showed antimicrobial activity against Streptococcus mutans and especially Candida albicans. The solvent fractions of Dendropanax morbifera $L{\acute{e}}veille$ showed strong antimicrobial activity against Streptococcus mutans and Candida albicans in n-hexane and butanol solvent fraction, respectively. Dendropanax morbifera $L{\acute{e}}veille$ extract also showed outstanding antioxidant activity. Butanol, ethyl acetate, and chloroform solvent fraction of Dendropanax morbifera $L{\acute{e}}veille$ tended to have increased antioxidant activity as the concentration increased. Dendropanax morbifera $L{\acute{e}}veille$ extract showed high cell survival rate in cytotoxicity test. CONCLUSION. Dendropanax morbifera $L{\acute{e}}veille$ extract turned out to have antimicrobial, antioxidant activity and cytophilicity. Based on these results, it is expected that Dendropanax morbifera $L{\acute{e}}veille$ is applicable as an ingredient for natural mouthwash and denture cleanser.

• Asian Pacific Journal of Cancer Prevention
• /
• 제17권7호
• /
• pp.3611-3614
• /
• 2016

Background: Propolis based preparations have a wide range of applications in various specialties of dentistry. The aim of this clinical trial was to test the efficacy of propolis as a mouthwash in the reduction of chemotherapy induced oral mucositis (OM) in a single center. Materials and Methods: In this randomised, controlled study patients undergoing chemotherapy were included consecutively and randomised to an experimental group receiving propolis mouthwash (n = 20) and a control group receiving diluted water (n=20). Oral mucositis, erythema and eating and drink ability were assessed at baseline and after 3 and 7 days using the World Health Organization (WHO) scale and the oral mucositis assessment scale (OMAS). Results: There were significant differences in OM, wound and erythema in propolis group compared to placebo, but no significant difference in eating and drink ability. However, it was interesting that 65% of the patients in the propolis group were completely healed at day 7 of the trial. No significant adverse events were reported by the patients. Conclusions: This study found that oral care with propolis as mouthwash for patients undergoing chemotherapy is an effective intervention to improve oral health. Our findings shouldlencourage health practitioners to apply propolis mouth rinse for the oral care of patients under chemotherapy.

• 분석과학
• /
• 제36권6호
• /
• pp.300-314
• /
• 2023

유통되고 있는 치약제 31품목(어린이치약 6품목 포함) 및 구중청량제 18품목(어린이구중청량제 2품목 포함)의 불소 함량, pH, 보존제와 타르색소의 함량을 분석하여 제품의 품질 실태를 조사하고 기준 및 제품의 표시 사항 일치 여부를 확인함으로써 소비자에게 올바른 정보를 제공하고자 하였다. 불소 함량을 측정한 결과 치약은 26건에서 48~1472 ppm, 구중청량제는 15건에서 85~225 ppm의 불소를 함유하고 있었고 치약제와 구중청량제의 불소 검출률은 각각 83.9 %, 83.3 %로 비슷한 수준을 나타냈다. 불소가 검출된 치약제와 구중청량제 41건 중 40건은 표시량의 90.7~109.8 %로 불소 함량 기준인 90.0~110.0 %에 적합하였으나, 치약 1건이 제품에 표시된 불소함량의 36.3 %로 부적합을 나타내었다. 치약의 pH는 5.1~9.4, 구중청량제의 pH는 4.2~6.2로 기준에 모두 적합하였다. 6종의 보존제 함량을 동시 분석한 결과 안식향산은 치약 6건과 구중청량제 9건 총 15건에서 30.6 %의 검출률로 가장 많이 검출되었고, 소르빈산은 구중 청량제 9건(검출률 18.4 %)에서 검출되었으며, 파라옥시벤조산메틸, 파라옥시벤조산에틸, 파라옥시벤조산프로필, 파라옥시벤조산부틸 등 4종은 모두 검출되지 않았다. 황색4호 등 10종의 타르색소 함량을 분석한 결과 치약 2건, 구중청량제 7건 총 9건에서 적색40호, 황색4호, 황색5호, 황색203호, 녹색3호, 청색1호 등 6가지 종류가 검출되었으며, 청색 1호가 가장 많이 검출되었다. 치약제와 구중청량제에서 검출된 불소 농도, 첨가된 보존제와 타르색소는 제품의 표시사항과 일치하였고 표시면에 잘 기재되어 있었다. 검출된 보존제와 타르색소는 일일섭취량허용량과 비교하여 위해도가 낮아 안전한 수준이었다.

• 대한화장품학회지
• /
• 제40권2호
• /
• pp.187-193
• /
• 2014

충치는 사람의 구강질환 중 가장 흔한 질환으로 Streptococcus mutans (S. mutans)균이 초기 충치를 형성하는데 매우 중요한 역할을 담당한다. Porphyromonas gingivalis (P. gingivalis)는 대표적인 구취 유발균으로 구취 형성에 중요한 휘발성 황화합물을 생성하는데 관여한다. 치주질환은 치은결체조직과 치조골의 파괴를 유발하여 치아의 상실을 초래할 수 있는 만성 염증성 질환으로 Prevotella intermedia (P. intermedia)가 원인균이다. 이번 연구에서는 cetylpyridinium chloride (CPC), sodium fluoride (NaF), 녹차 추출액, 솔잎 추출액을 유효성분으로 하는 마우스워시 제품을 사용하여 S. mutans 균을 포함, 구강질환 균으로 널리 알려진 P. gingivalis, P. intermedia 대해 항균 효과를 확인하고자 하였다. 그 결과 시험군의 경우 S. mutans, P. gingivalis 에 대해 30 s 내에 4.00 Log, 4.68 Log의 사멸력을 확인하였고, P. intermedia의 경우 30 s 2.40 Log, 60 s 2.70 Log 사멸력을 확인하였다. 또한 Dentocult SM Strip mutans (SM Strip) 염색방법을 적용하여 S. mutans 균의 감소여부를 시각적 자료로 쉽게 확인할 수 있었다. 이와 같은 결과를 통해 CPC, NaF, 녹차 추출액, 솔잎 추출액을 포함한 마우스워시 제품은 구강균 사멸을 통해 충치 및 구취와 같은 구강질환 예방에 효과가 있을 것으로 기대한다.

• 치위생과학회지
• /
• 제18권4호
• /
• pp.265-270
• /
• 2018

본 연구는 일부 시판 구강양치액의 화학적 특성을 조사하고, 구강양치액이 치아에 무기질 소실에 영향을 미치는지 확인하고자 하였다. 국내 3대 대형마트에서 공통으로 시판되는 구강양치액 5개 제품을 선정하였다(페리오토탈7 스트롱후레쉬[PS], 가그린 오리지널[GO], 가그린 제로[GZ], 리스테린 시트러스[LC], 리스테린 쿨민트[LM]). 구강양치액의 구성 성분과 pH와 적정산도를 조사하였다. 각 구강양치액 군별로 6개의 우치시편을 제작하였다. 각 구강양치액 30ml에 우치 시편 6개씩을 1분, 30분, 90분, 120분간 침적하였으며, 이때 $36.5^{\circ}C$ 교반 배양기에 위치하였다. 이후 치아의 무기질 소실 정도는 QLF-D를 이용하여 정상치아 대비구강양치액 노출 부위의 무기질 소실 정도(${\Delta}F$)를 분석하였다. 구강양치액군 간의 ${\Delta}F$의 차이를 Kruskal-Wallis H검정을 시행하여 알아보았다(${\alpha}=0.05$). 구강양치액의 성분은 리스테린 제품과 그 외 제품별로 차이가 있었으며, pH는 4.09~6.75의 범위를 보였다. 적정산도는 PS 제품이 평균 0.63 ml로 가장 적었으며 LM은 9.25 ml로 조사 제품 중 가장 높은 적정산도 값을 보였다. 리스테린 제품, LC와 LM에 90분 이상 치아 시편을 침적하였을 때 매우 적은 무기질 소실이 확인되었으나 통계적으로는 무기질 소실이 일어나지 않은 군과 유의한 차이가 확인되지 않았다(p>0.05). 결론적으로 시판 구강양치액 5종 모두 치아의 법랑질에는 위해가 없음을 확인하였다.

• Journal of Periodontal and Implant Science
• /
• 제31권2호
• /
• pp.401-420
• /
• 2001

A novel glucanhydrolase from a mutant of Lipomyces starkeyi(KSM 22)has been shown effective in hydrolysis of mutan, reduction of mutan formation by Streptococcus mutans and removal pre-formed sucrose-dependent adherent microbial film and Lipomyces starkeyi KSM 22 dextranase has been strongly bound to hydroxyapatitie. These in vitro properties of Lipomyces starkeyi KSM 22 dextranase are desirable for its application as a dental plaque control agent. This study was performed to determine oral hygiene benefits and safety of dextranase(Lipomyces starkeyi KSM 22 dextranase)-containing mouthwash in human experimental gingivitis. This 3-week clinical trial was placebo-controlled double-blind design evaluating 1U/ml dextranase mouthwash and 0.12% chlorhexidine mouthwash. A total 39 systemically healthy subjects, who had moderate levels of plaque and gingivitis were included. At baseline, 1, 2 and 3 weeks, subjects were scored for plaque(Silness and $L{\ddot{o}e$ plaque index and plaque severity index), gingivitis($L{\ddot{o}e$ and Silness gingival index), and at baseline and 3 weeks of experiment, subjects were scored for plaque(Turesky-Quingley-Hein's plaque index and plaque severity index), tooth stain(Area and severity index system by Lang et al). Additionally, oral mucosal examinations were performed and subjects questioned for adverse symptoms. Two weeks after pre-experiment examinations and a professional prophylaxis, the subjects provided with allocated mousewash and instructed to use 20-ml volumes for 30s twice dailywithout toothbrushing. All the groups showed significant increase in plaque accumulation since 1 week of experiment. During 3 weeks' period, the dextranase group showed the least increase in plaque accumulation of Silness and $L{\ddot{o}e$ plaque index, compared to the chlorhexidine and placebo groups, but chlorhexidine group showed the least increase inplaque accumulation of Turesky-Quingley-Hein's plaque index. As for gingival inflammation, all the groups showed significant increase during 3 weeks of experiment. The dextranase group also showed the least increase in gingival index score, compared to the chlorhexidine as well as the placebo groups. Whereas the tooth stain was increased significantly in the chlorhexidine group, compared to the baseline score and the placebo group since 3 weeks of mouthrinsing. It was significantly increased after 3 weeks in the dextranase group, still less severe than the chlorhexidine group. As for the oral side effect, the dextranase group showed less tongue accumulation, bad taste, compared to the chlorhexidine group. From these results, mouthrinsing with Lipomyces starkeyi KSM 22 dextranase was comparable to 0.12% chlorhexidine mouthwashin inhibition of plaque accumulation and gingival inflammation and local side effects were if anything less frequent and less intense than chlorhexidine, in human experimental gingivitis. All data had provided positive evidence for Lipomyces starkeyi KSM 22 dextranase as an antiplaque agent and suggested that further development of dextranase formulations for plaque control are warranted.

• Journal of Periodontal and Implant Science
• /
• 제20권2호
• /
• pp.162.1-162.1
• /
• 1990

• 구강회복응용과학지
• /
• 제38권1호
• /
• pp.1-8
• /
• 2022

목적: 본 연구의 목적은 염화나트륨을 배합한 구중청량제의 치면세균막, 잇몸 염증 및 구취에 대한 효과를 임상시험을 통하여 평가하고자 하였다. 연구 재료 및 방법: 본 시험은 12주간 연구대상자에게 표준세치제를 이용하여 칫솔질을 하루에 총 3회를 실시하도록 하고, 칫솔질 후에 군별로 제공된 각각의 구중청량제를 입안에서 가글하고 뱉어내도록 교육하였다. 총 5회에 걸쳐 잇몸 염증 검사, 치면세균막 변화, 구취 검사를 시행하여 효능을 평가하였다. 본 연구의 수집된 데이터는 IBM SPSS Statistics 24.0을 이용하여 통계적으로 분석하였으며, 통계적 유의성 판단을 위한 기준으로 유의수준 0.05를 사용하였으며, 그룹 간 비교를 위한 2-sample t-test와 그룹 내 비교를 위한 paired t-test로 분석되었습니다. 결과: PMA 지수 측정결과 실험군의 대조군 대비 잇몸 염증 개선 효과율은 8주 후 107.63%, 12주 후 73.08%를 나타냈다. PHP index 측정 결과 실험군의 대조군 대비 프라그 개선 효과율은 8주 후 79.37%, 12주 후 74.06%를 나타났다. 실험군의 대조군 대비 구취 개선 효과율은 8주 후 65.06%, 12주 후 99.33%를 나타냈다. 결론: 이러한 연구 결과 염화나트륨 및 녹차 추출액, 일불소인산나트륨을 배합한 구중청량제를 사용할 경우 효과적인 잇몸 염증 완화효과를 기대할 수 있으며, 추가적으로 개선된 치면세균막 제거 효과 및 구취 제거 효과를 기대할 수 있음을 확인할 수 있었다.

• Journal of Periodontal and Implant Science
• /
• 제34권1호
• /
• pp.195-204
• /
• 2004

A novel glucanhydrolase from Lipomyces starkeyi KSM 22 has been suggested as a promising anti-plaque agent because it has been shown to have additional amylase activity and mutanase activity besides dextranase activity and to strongly bind to hydroxyapatite. Mouthrinsing with Lipomyces starkeyi KSM 22 glucanhydrolase solution was comparable to 0.12% chlorhexidine mouthwash in inhibition of plaque accumulation and gingival inflammation and local side effects were less frequent and less intense in human experimental gingivitis. In this study, Lipomyces starkeyi KSM 22 glucanhydrolase mouthrinses (1 and 2 unit/ml) were compared with a control mouthrinse (commercial 0.01% benzethonium chloride mouthrinse, $Caregargle^{(R)}$, Hanmi Pharmaceuticals) in the ability to inhibit plaque formation. A 3-replicate clinical trial using 4-day plaque regrowth model was used. Fifteen volunteers were rendered plaque-free on the 1st day of each study period, ceased toothcleansing, and rinsed 2X daily with allocated mouthrinse thereafter. On day 5, plaque accumulation was scored and the washout periods was 9 days for the next trial. Lipomyces starkeyi KSM22 glucanhydrolase(1 unit and 2 unit)- containing mouthrinse resulted in Significantly lower plaque formation in plaque area and thickness, compared to the control mouthrinse. There was no significant difference in plaque inhibition between enzyme-mouthrinses at 2 different concentrations used. This glucanhydrolase- containing mouthwash resulted in significantly lower plaque area severity index score and tended to have lower plaque thickness severity index score than those of control mouthrinse. But there was no significant difference according to the enzyme concentration. From these results, Lipomyces starkeyi KSM 22 glucanhydrolase-containing benzethonium chloride mouthrinse has greater anti-plaque effect than the commercial mouthrinse alone. Therefore this glucanhydrolase preparation is a promising agent for new mouthwash formulation in the near future.